study suggests zoloft lexapro top treating depression .
antidepressant drug created equal according author one study ever systematically analyzed compared new generation medicine treating depression .
analysis 12 drug two came top effective best tolerated treatment : sertraline zoloft escitalopram lexapro .
venlafaxine effexor mirtazapine remeron rounded top four effectiveness venlafaxine also among four drug patient likely quit taking side effect .
reboxetine edronax le effective rest .
psychiatrist treating depressed patient every day sense medication best current study nail say sagar parikh university toronto .
parikh wrote comment accompanying study published current issue lancet say finding enormous implication first time offer doctor unbiased way recommend treatment .
add give patient gold standard reliable information especially since study author plan make finding available free web .
fast say gerald gartlehner coauthored review benefit risk 12 drug published last november annals internal medicine .
colleague concluded based review done gartlehner practice center chapel hill north carolina clinically meaningful evidence one drug better rest .
instead argued decision drug use based factor cost side effect .
current study andrea cipriani university verona italy colleague used new technique called make comparison among 12 drug incorporating 117 randomized controlled trial including patient .
little scientific evidence relative effectiveness drug study compare one handful others placebo often funded maker particular drug bias finding favor researcher note .
used two measurement gauge drug effectiveness tolerability : percentage patient showed least 50 percent improvement symptom measured one two scale scored much improved much improved eight week treatment six twelve week data available percentage patient dropped study eight week reason .
12 drug included bupropion citalopram duloxetine escitalopram fluoxetine fluvoxamine milnacipran mirtazapine paroxetine reboxetine sertraline venlafaxine .
author use funding drug manufacturer conduct study .
unbiased approach combining maximum possible data comparing large number drug rather one versus select handful much confidence finding say parikh .
basically parikh explains cipriani colleague able make comparison among drug studied using effectiveness compared prozac best studied drug kind common currency .
limitation indirect approach used nonetheless think best available present .
analysis need updated regularly include new upcoming evidence cipriani coauthor john geddes director centre mental health university oxford united kingdom said via .
finding mean everyone put zoloft lexapro seen suggesting people drug go cipriani geddes say .
good choice available since everyone benefit particular drug also seem lot product offer additional benefit cost author add .
suggest future study compare new antidepressant sertraline rather placebo selection drug .
requiring new treatment show either greater efficacy acceptability existing standard therapy would serve disincentive development agent offer little patient increased cost write .
according gartlehner danube university krems austria approach cipriani et .
al used serious downside acknowledge .
also argues use odds ratio rather relative risk led overestimation difference among various drug .
difference statistically significant probably clinically relevant gartlehner said .
quite stretch say clinically important difference exist commonly prescribed antidepressant .
colleague see difference among drug profile could fact relevant patient gartlehner said argues finding venlaxafine caused nausea vomiting sertraline associated diarrhea well fact drug must taken several time day others taken le often important consideration along cost .
parikh difference effectiveness tolerability cipriani identified make real difference patient .
magnitude difference huge term effectiveness .
genuine modest parikh said .
say patient want strongest possible drug want one least likely give side effect want balance ? .
added allows dialogue say suit ? .
able engage patient dialogue much better chance patient sticking treatment able tailor treatment individual preference .
